The latest “State of Implementation” report (Stand van Uitvoering) from the Dutch Medicines Evaluation Board (MEB) highlights key challenges facing medicines regulation and patient access in a rapidly changing environment.
Four key challenges stand out:
- New European legislation
New EU rules on medicines, devices, sustainability and chemicals require major changes to systems, processes and resources. - Pressure on medicine availability
Ongoing shortages and supply disruptions continue to challenge patient access and continuity of care. - Barriers to data sharing
Legal barriers to information exchange can delay processes and reduce efficiency. - Growing misinformation and demand for trusted information
Growing misinformation increases the need for clear, reliable and accessible health information.
These challenges highlight the need for agile regulation, strong collaboration and continued investment in people and technology.
The goal remains the same: ensuring patients can rely on safe, effective and available medicines.
At Starodub B.V., we share this commitment, helping pharmaceutical companies navigate regulatory change and maintain patient access to medicines. Contact us at [email protected] to discuss how these developments may impact your business.
